Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 11, 2016
[ Mon, Jan 11th 2016
] - WOPRAI
[ Mon, Jan 11th 2016
] - WOPRAI
[ Mon, Jan 11th 2016
] - WOPRAI
[ Mon, Jan 11th 2016
] - WOPRAI
[ Mon, Jan 11th 2016
] - WOPRAI
[ Mon, Jan 11th 2016
] - WOPRAI
Sun, January 10, 2016
[ Sun, Jan 10th 2016
] - WOPRAI
Fri, January 8, 2016
[ Fri, Jan 08th 2016
] - WOPRAI
[ Fri, Jan 08th 2016
] - WOPRAI
[ Fri, Jan 08th 2016
] - WOPRAI
[ Fri, Jan 08th 2016
] - WOPRAI
[ Fri, Jan 08th 2016
] - WOPRAI
[ Fri, Jan 08th 2016
] - WOPRAI
Thu, January 7, 2016
[ Thu, Jan 07th 2016
] - WOPRAI
[ Thu, Jan 07th 2016
] - WOPRAI
[ Thu, Jan 07th 2016
] - WOPRAI
Wed, January 6, 2016
[ Wed, Jan 06th 2016
] - WOPRAI
Maury Raycroft Upgraded (BCRX) to Strong Buy and Held Target at $14 on, Jan 6th, 2016
Maury Raycroft of Jefferies, Upgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Strong Buy and Held Target at $14 on, Jan 6th, 2016.
Maury has made no other calls on BCRX in the last 4 months.
There is 1 other peer that has a rating on BCRX. Out of the 1 peers that are also analyzing BCRX, 0 agree with Maury's Rating of Hold.
This is the rating of the analyst that currently disagrees with Maury
- Tazeen Ahmad of "B of A Securities" Downgraded from Hold to Sell on, Wednesday, November 11th, 2015
Similar Stocks and Investing Articles
[ Thu, Oct 15th 2015
] - WOPRAI
[ Wed, Sep 09th 2015
] - WOPRAI
[ Thu, Dec 04th 2014
] - WOPRAI
[ Mon, Mar 10th 2014
] - WOPRAI
[ Fri, Dec 06th 2013
] - WOPRAI
[ Wed, Nov 06th 2013
] - WOPRAI
[ Fri, Sep 06th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Mon, Jan 14th 2013
] - WOPRAI
[ Mon, Mar 19th 2012
] - WOPRAI